PA
TASK icon

PharVision Advisers’s TaskUs TASK Stock Holding History

PharVision Advisers’s Portfolio TASK Stock Details TASK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51.7K Buy
+11,056
New +$67.1K 0.98% 58
2026
Q1 		– Sell
-22,193
Closed -$262K – 586
2025
Q4 		$262K Buy
+22,193
New +$284K 0.13% 363
2025
Q2 		– Sell
-17,245
Closed -$235K – 425
2025
Q1 		$235K Buy
+17,245
New +$259K 0.33% 149

Other funds holding TASK

Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
TI
Think Investments San Francisco, California $847M AUM 88.1% 1-Year Est. Return
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
DI
Dalton Investments Las Vegas, Nevada $111M AUM 7.89% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $40.6B AUM 38.65% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

PharVision Advisers's TASK Position: Q2 2026 in Review

PharVision Advisers opened a new position in TaskUs (TASK) in Q2 2026: 11,056 shares worth $51.7K. The stake represents 0.98% of the portfolio and ranks #58 among its holdings. This is a return to the name: PharVision Advisers previously reported a position in TASK as recently as Q4 2025.

PharVision Advisers first reported a position in TASK in Q1 2025 and has held it in 3 quarters since. The position peaked at $262K in Q4 2025. 104 funds tracked by Wall St. Rank hold TASK as of Q2 2026.

  • PharVision Advisers held 11,056 shares of TaskUs worth $51.7K as of Q2 2026.
  • TaskUs was a new PharVision Advisers position in Q2 2026.
  • TaskUs made up 0.98% of PharVision Advisers's portfolio in Q2 2026, its #58 holding.
  • PharVision Advisers first reported a position in TaskUs in Q1 2025 and has held it in 3 quarters since.
  • PharVision Advisers's TaskUs position peaked at $262K in Q4 2025.
  • 104 funds tracked by Wall St. Rank held TaskUs as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.